Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer

NCT00061815 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: oxaliplatin
DRUG: leucovorin
DRUG: 5-fluorouracil
DRUG: 5-fluorouracil
BIOLOGICAL: cetuximab

Sponsor

Eli Lilly and Company

Collaborators

[object Object]